Search Results
Showing results 1 to 20 of 117.
Article
Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts
January 17, 2024
Article
HARmonized protocol template to enhance reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force
January 01, 2023
Article
HARmonized protocol template to enhance reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force
October 01, 2022
Article
Risk assessment of acute myocardial infarction and stroke associated with long-acting muscarinic antagonists, alone or in combination, versus long-acting beta2-agonists
August 02, 2022
Article
Incidence of acute renal failure in patients using levetiracetam versus other antiseizure medications: A voluntary post-authorization safety study
July 01, 2022
Article
Characteristics of new users of aclidinium bromide, aclidinium/formoterol, and other COPD medications in the United Kingdom, Denmark, and Germany
April 01, 2022
Article
Where to begin?: Thirty must-read papers for newcomers to pharmacoepidemiology
February 01, 2022
Article
Long-term risk of skin cancer and lymphoma in users of topical tacrolimus and pimecrolimus: Final results from the extension of the cohort study protopic joint European longitudinal lymphoma and skin cancer evaluation (JOELLE)
December 01, 2021
Article
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe
October 01, 2021
Article
Cardiovascular risk in users of mirabegron compared with users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, multinational, cohort study
August 01, 2021
Article
A cohort study to evaluate the risk of hospitalisation for congestive heart failure associated with the use of aclidinium and other chronic obstructive pulmonary disease medications in the UK clinical practice research datalink
June 10, 2021
Article
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder
May 04, 2021
Article
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
February 01, 2021
Article
Comparative cardiovascular safety of strontium ranelate and bisphosphonates: A multi-database study in 5 EU countries by the EU-ADR Alliance
December 01, 2020
Article
Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries
October 28, 2020
Article
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder
April 01, 2020
Article
Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: A multi-national cohort study in 5 EU countries by the EU-ADR Alliance
February 05, 2020
Article
Impact of risk minimisation measures on the use of strontium ranelate in Europe: A multi-national cohort study in 5 EU countries by the EU-ADR Alliance
November 06, 2019
Article
Validity of hospital ICD-10-GM codes to identify acute liver injury in Germany
October 01, 2019
Article
Agomelatine post-authorization safety studies program: Comprehensive results
August 20, 2019